Troponin Elevation in Pericarditis
Yes, troponin can be elevated in patients with isolated pericarditis, occurring in approximately 32-60% of cases, but this elevation does not indicate a worse prognosis and should not be confused with acute coronary syndrome. 1
Clinical Significance and Frequency
Troponin elevation in acute pericarditis is a common finding that reflects epicardial inflammation rather than ischemic myocardial damage. The 2015 ESC Guidelines explicitly recognize that patients with concomitant myocardial involvement may present with elevation of markers of myocardial injury (i.e. creatine kinase, troponin) 1. Research data demonstrates:
- Troponin I is detectable in 32-49% of pericarditis cases 2, 3
- Significant elevation (>1.5 ng/mL) occurs in 7-22% of patients 2, 3
- The elevation reflects superficial myocardial or epicardial inflammation, not coronary artery disease 3
Distinguishing Pericarditis from Myopericarditis
The ESC Guidelines provide clear diagnostic criteria to differentiate these entities:
Isolated Pericarditis: Meets diagnostic criteria for acute pericarditis without troponin elevation or with troponin elevation but normal left ventricular function on echocardiography/CMR 1
Myopericarditis: Patients with definite acute pericarditis criteria PLUS elevated troponin WITHOUT newly developed focal or diffuse left ventricular dysfunction 1
Perimyocarditis: Elevated troponin WITH new-onset reduction of left ventricular function, suggesting predominant myocarditis 1
Clinical Associations with Troponin Elevation
When troponin is elevated in pericarditis, it correlates with:
- Younger age (most consistent finding across studies) 2, 4, 3
- Male gender 2
- ST-segment elevation on ECG (93% sensitivity but only 43% specificity) 2, 3
- Pericardial effusion at presentation 2
- Recent viral infection 3
Prognostic Implications
Critically, troponin elevation in pericarditis does NOT predict adverse outcomes, which fundamentally distinguishes it from acute coronary syndromes. Multiple studies confirm:
- No increased risk of recurrent pericarditis (18.4% vs 18.8% in troponin-positive vs negative) 2
- No increased risk of constrictive pericarditis or cardiac tamponade 2, 4
- No residual left ventricular dysfunction 2, 4
- Paradoxically, elevated troponin may actually predict LOWER recurrence rates (4% vs 17%) 5
After mean follow-up of 24-51 months, outcomes remain similar regardless of troponin status 2, 4.
Clinical Management Implications
Assessment of troponin is recommended in all patients with suspected acute pericarditis (Class I, Level C recommendation) 1. When elevated:
Rule out acute coronary syndrome - Coronary angiography is recommended based on clinical presentation and risk factors 1
Consider CMR imaging - Recommended to confirm myocardial involvement and exclude ischemic necrosis 1
Hospitalization is indicated when myocardial involvement is suspected for monitoring and differential diagnosis 1
Treatment remains similar to isolated pericarditis - NSAIDs (ibuprofen 1200-2400 mg/day) or aspirin (1500-3000 mg/day), though some recommend reduced dosages in myopericarditis 1
Important Caveats
- Troponin may be normal initially and rise over subsequent days, with peak levels typically occurring around day 5 post-symptom onset 6, 7
- ST-segment elevation has high sensitivity (93%) but low specificity (43%) for detecting myocardial injury in pericarditis 3
- The increased sensitivity of modern troponin assays has greatly increased the reported number of myopericarditis cases 1
- Rare analytical interference can cause false-positive troponin results that don't fit the clinical picture 8
In summary: Troponin elevation occurs frequently in pericarditis, reflects epicardial inflammation rather than ischemia, and unlike in acute coronary syndromes, does not indicate poor prognosis or require aggressive cardiac interventions beyond standard pericarditis management.